Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Theranostic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06111417
What this trial is testing

Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners

Who this might be right for
Breast Cancer
Centre Georges Francois Leclerc 150
Large-scale testing (Phase 3)Looking for participantsNCT06297096
What this trial is testing

Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland 86
Not applicableStudy completedNCT05457647
What this trial is testing

Theranostic Guided Riboflavin/UV-A Corneal Cross-linking

Who this might be right for
Keratoconus
Regensight 50
Not applicableStudy completedNCT06489951
What this trial is testing

Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker

Who this might be right for
Overactive BladderPediatric Disorder
Xing Liu 180
Not applicableStudy completedNCT02372448
What this trial is testing

Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients

Who this might be right for
Lung Neoplasms
Centre Hospitalier Universitaire de Nice 206
Early research (Phase 1)Looking for participantsNCT06389123
What this trial is testing

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

Who this might be right for
Metastatic Cancer
University of California, Davis 40
Testing effectiveness (Phase 2)Looking for participantsNCT07208240
What this trial is testing

Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial.

Who this might be right for
High Risk Prostate Cancer
Rabin Medical Center 20
Not applicableEnded earlyNCT03016260
What this trial is testing

RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis

Who this might be right for
RheumatoId Arthritis
TcLand Expression S.A. 250
Testing effectiveness (Phase 2)Looking for participantsNCT04868604
What this trial is testing

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Clarity Pharmaceuticals Ltd 54
Testing effectiveness (Phase 2)Ended earlyNCT04023331
What this trial is testing

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

Who this might be right for
NeuroblastomaRelapsed NeuroblastomaRefractory Neuroblastoma
Clarity Pharmaceuticals Ltd 21
Early research (Phase 1)UnknownNCT04849247
What this trial is testing

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

Who this might be right for
177Lu-DOTA-FAPI68Ga-DOTA-FAPITheranostic
The First Affiliated Hospital of Xiamen University 30
Early research (Phase 1)Ended earlyNCT07076550
What this trial is testing

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Who this might be right for
Melanoma MetastaticUveal Melanoma, MetastaticMucosal Melanoma
Alpha-9 Oncology USA Inc. 5
Not applicableActive Not RecruitingNCT04769817
What this trial is testing

ProsTIC Registry of Men Treated With PSMA Theranostics

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate Cancer
Peter MacCallum Cancer Centre, Australia 500
Not applicableLooking for participantsNCT07221825
What this trial is testing

Low-Count Quantitative SPECT for Men Treated With Radium-223

Who this might be right for
Prostate CancerCancer of the Prostate
Washington University School of Medicine 38
Testing effectiveness (Phase 2)Looking for participantsNCT05636618
What this trial is testing

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Who this might be right for
Neuroendocrine Tumors UnresectableNeuroendocrine Tumor MetastaticGastroenteropancreatic Neuroendocrine Tumor+4 more
Perspective Therapeutics 300
Not applicableStudy completedNCT05680675
What this trial is testing

Dual-Tracer Theranostic PET

Who this might be right for
Neuroendocrine TumorsProstate Cancer
University of Utah 50
Testing effectiveness (Phase 2)UnknownNCT03463551
What this trial is testing

Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic

Who this might be right for
Acute Ischaemic Stroke
NHS Greater Glasgow and Clyde 18
Early research (Phase 1)Study completedNCT05420727
What this trial is testing

Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach

Who this might be right for
Soft Tissue Sarcoma
John O. Prior 14
Very early researchActive Not RecruitingNCT06148636
What this trial is testing

A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor of the LungNeuroendocrine Tumor Grade 1+2 more
David Bushnell 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178938
What this trial is testing

Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases

Who this might be right for
Solid TumorsHER2-positive Breast Cancer
MedSIR 10
Next Page